Inhibrx Biosciences, Inc. (INBX) — Cash Flow Quality Index
Inhibrx Biosciences, Inc. (INBX) has a Cash Flow Quality Index of -0.03x as of June 2024. Operating cash flow of $-57.36 Million is below net income of $1.83 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Inhibrx Biosciences, Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Inhibrx Biosciences, Inc. Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Inhibrx Biosciences, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see INBX cash flow metrics.
Annual Cash Flow Quality Index for Inhibrx Biosciences, Inc. (2024–2024)
Year-by-year earnings quality comparison for Inhibrx Biosciences, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.12x | $-194.41 Million | $1.69 Billion | — |